What is IPO Subscription?

Learn how IPO subscription works, the significance of oversubscription, and how to track QIB, NII, and Retail subscription numbers.

Understanding the Demand Metric

An IPO Subscription indicates the level of demand for the shares offered by a company during its Initial Public Offering. It simply measures how many shares investors have bid for compared to the number of shares actually being offered to the public.

For example, if a company offers 10 lakh shares, but receives bids for 50 lakh shares, the IPO is said to be "5 times (5x) subscribed".

Investor Categories

IPO subscriptions are tracked across different categories of investors:

  • QIBs (Qualified Institutional Buyers): Mutual funds, foreign portfolio investors, and large banks. Strong QIB subscription is usually a green flag, as "smart money" is buying in.
  • NIIs (Non-Institutional Investors): High Net Worth Individuals (HNIs) who invest more than ₹2 Lakhs in an IPO.
  • RIIs (Retail Individual Investors): Regular investors bidding up to ₹2 Lakhs. High retail subscription usually points to huge hype, though it makes allocation difficult.

Oversubscription and Listing Gains

When an IPO is oversubscribed, demand outstrips supply. Since the company can only issue a fixed number of shares, the allotment process becomes a lottery. The investors who did not receive an allotment in the IPO often flock to buy the shares on the open market once the stock lists.

This massive pent-up demand is what causes Listing Gains—where a stock lists on the exchange at a price significantly higher than its IPO issue price.

Key Takeaways

  • High subscription multiples (e.g., 50x or 100x) strongly indicate positive listing gains.
  • Watch the QIB numbers closely; they represent institutional conviction.
  • Undersubscribed IPOs (less than 1x) may struggle on listing day and could list at a discount.

Conclusion

Tracking live subscription numbers is one of the best ways to gauge an IPO's success before it even hits the exchange. Stay ahead of the curve by tracking live GMPs and subscriptions using our IPO Radar.